"North Carolina Halts Funding for Obesity Medications Due to Wegovy Expenses"

TL;DR Summary
North Carolina's state employees will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound starting April 1, as the state's health plan board voted to end all coverage of medications for weight loss due to ballooning costs, with medications like Wegovy alone costing the plan $100 million last year. This decision comes after a sharp criticism from the state treasurer, Dale Folwell, who accused Novo Nordisk of price gouging on Wegovy.
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
1 min
vs 2 min read
Condensed
76%
315 → 75 words
Want the full story? Read the original article
Read on The New York Times